Martingale Asset Management Reduces McKesson Holdings

Investment firm lowers stake in pharmaceutical distributor by 7.3% in Q3

Mar. 13, 2026 at 10:52am

Got story updates? Submit your updates here. ›

Martingale Asset Management L.P. lowered its stake in McKesson Corporation (NYSE:MCK) by 7.3% during the third quarter, according to a recent 13F filing with the SEC. The firm now owns 31,985 shares of the company's stock, valued at $24,710,000 as of its most recent filing.

Why it matters

As one of the largest healthcare services and pharmaceutical distribution companies, changes in institutional ownership of McKesson stock can signal broader trends in the industry and investor sentiment around the company's performance and outlook.

The details

Martingale Asset Management sold 2,522 shares of McKesson stock during the third quarter. The firm now holds a total of 31,985 shares, down from 34,507 shares previously. McKesson's stock price has risen steadily over the past year, reaching a 52-week high of $999 in early 2026.

  • Martingale Asset Management filed its 13F report for the third quarter of 2025 on March 13, 2026.

The players

Martingale Asset Management L.P.

An investment management firm that provides a range of equity and fixed income strategies to institutional and individual investors.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and healthcare technology solutions.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Martingale's McKesson holdings, while relatively small, could signal a broader shift in investor sentiment around the healthcare distribution sector as the industry faces evolving challenges and market dynamics.